glp-1 parkinson's disease lancet receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits The glucagon-like peptide 1 (GLP)

These typically involve blood glucose, kidney and liver performance, and other important health indicators

The proper functioning of these receptors is crucial for incretin therapy success and here we review several mechanisms at the cellular and molecular level that influence an individuals response to incretin therapy

Current Diabetes Reviews, 17 (3), 293-303

Van Woert MH, Mueller PS, Ambani LM, Rathey U

Additionally, people who regularly take vitamin B-12 injections or supplements gain fewer pounds in ten years than those who do not take the vitamin

Typical usage involves subcutaneous injection of 200500 micrograms (g) daily for 46 weeks